• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质基因组分析揭示非小细胞肺癌亚型与染色体不稳定性和肿瘤微环境的关系。

Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment.

机构信息

Department of Applied Chemistry, Institute of Natural Science, Kyung Hee University, Yongin, 17104, Republic of Korea.

Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul, 02454, Republic of Korea.

出版信息

Nat Commun. 2024 Nov 23;15(1):10164. doi: 10.1038/s41467-024-54434-4.

DOI:
10.1038/s41467-024-54434-4
PMID:39580524
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11585665/
Abstract

Non-small cell lung cancer (NSCLC) is histologically classified into lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LSCC). However, some tumors are histologically ambiguous and other pathophysiological features or microenvironmental factors may be more prominent. Here we report integrative multiomics analyses using data for 229 patients from a Korean NSCLC cohort and 462 patients from previous multiomics studies. Histological examination reveals five molecular subtypes, one of which is a NSCLC subtype with PI3K-Akt pathway upregulation, showing a high proportion of metastasis and poor survival outcomes regardless of any specific NSCLC histology. Proliferative subtypes are present in LUAD and LSCC, which show strong associations with whole genome doubling (WGD) events. Comprehensive characterization of the immune microenvironment reveals various immune cell compositions and neoantigen loads across molecular subtypes, which predicting different prognoses. Immunological subtypes exhibit a hot tumor-enriched state and a higher efficacy of adjuvant therapy.

摘要

非小细胞肺癌(NSCLC)在组织学上可分为肺腺癌(LUAD)和肺鳞状细胞癌(LSCC)。然而,一些肿瘤在组织学上存在模糊性,其他病理生理特征或微环境因素可能更为突出。在这里,我们报告了使用来自韩国 NSCLC 队列的 229 名患者和之前多组学研究的 462 名患者的数据进行的综合多组学分析。组织学检查显示有五个分子亚型,其中一个是 NSCLC 亚型,其 PI3K-Akt 通路上调,无论任何特定的 NSCLC 组织学如何,其转移比例较高,生存结局较差。增殖亚型存在于 LUAD 和 LSCC 中,与全基因组加倍(WGD)事件有很强的关联。对免疫微环境的全面描述揭示了不同分子亚型的各种免疫细胞组成和新抗原负荷,这些都预示着不同的预后。免疫亚型表现出热肿瘤富集状态和辅助治疗的更高疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/2411a557e487/41467_2024_54434_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/b4d26e8d08d9/41467_2024_54434_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/aa9a51fb2b00/41467_2024_54434_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/8ee5a904311d/41467_2024_54434_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/1ec2d12a7945/41467_2024_54434_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/88cd757daa14/41467_2024_54434_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/2411a557e487/41467_2024_54434_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/b4d26e8d08d9/41467_2024_54434_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/aa9a51fb2b00/41467_2024_54434_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/8ee5a904311d/41467_2024_54434_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/1ec2d12a7945/41467_2024_54434_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/88cd757daa14/41467_2024_54434_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11c7/11585665/2411a557e487/41467_2024_54434_Fig6_HTML.jpg

相似文献

1
Proteogenomic analysis reveals non-small cell lung cancer subtypes predicting chromosome instability, and tumor microenvironment.蛋白质基因组分析揭示非小细胞肺癌亚型与染色体不稳定性和肿瘤微环境的关系。
Nat Commun. 2024 Nov 23;15(1):10164. doi: 10.1038/s41467-024-54434-4.
2
Insights into the heterogeneity of the tumor microenvironment in lung adenocarcinoma and squamous carcinoma through single-cell transcriptomic analysis: Implications for distinct immunotherapy outcomes.通过单细胞转录组分析深入了解肺腺癌和鳞癌肿瘤微环境的异质性:对不同免疫治疗结果的影响。
J Gene Med. 2024 Jun;26(6):e3694. doi: 10.1002/jgm.3694.
3
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments.肺腺癌的分子亚型表现出不同的免疫肿瘤微环境。
Cancer Sci. 2024 Jun;115(6):1763-1777. doi: 10.1111/cas.16154. Epub 2024 Mar 25.
4
Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma.PCDHGA12 在肺腺癌和鳞癌中的差异预后影响及潜在分子机制。
Int Immunopharmacol. 2024 Sep 30;139:112727. doi: 10.1016/j.intimp.2024.112727. Epub 2024 Jul 26.
5
A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.多组学整合分析早期非小细胞肺癌的预后相关分子亚型。
BMC Cancer. 2021 Feb 6;21(1):128. doi: 10.1186/s12885-021-07846-0.
6
Immune subgroup analysis for non-small cell lung cancer may be a good choice for evaluating therapeutic efficacy and prognosis.免疫亚组分析可能是评估非小细胞肺癌治疗效果和预后的一个较好选择。
Aging (Albany NY). 2021 May 11;13(9):12691-12709. doi: 10.18632/aging.202941.
7
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.肺腺癌和肺鳞癌基因表达亚型在肿瘤免疫格局上表现出显著差异。
J Thorac Oncol. 2017 Jun;12(6):943-953. doi: 10.1016/j.jtho.2017.03.010. Epub 2017 Mar 21.
8
Differential expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma.人类肺鳞癌和腺癌中表观遗传改变的差异表达。
Oncol Rep. 2021 May;45(5). doi: 10.3892/or.2021.8029. Epub 2021 Mar 31.
9
Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients.中国非小细胞肺癌患者中腺癌和鳞状细胞癌主要组织学亚型的突变特征比较研究。
Thorac Cancer. 2020 Jan;11(1):103-112. doi: 10.1111/1759-7714.13208. Epub 2019 Nov 6.
10
Transcriptomics profiling of the non-small cell lung cancer microenvironment across disease stages reveals dual immune cell-type behaviors.非小细胞肺癌微环境在疾病各阶段的转录组特征分析揭示了双重免疫细胞类型行为。
Front Immunol. 2024 Oct 31;15:1394965. doi: 10.3389/fimmu.2024.1394965. eCollection 2024.

引用本文的文献

1
The dark matter in cancer immunology: beyond the visible- unveiling multiomics pathways to breakthrough therapies.癌症免疫学中的暗物质:超越可见——揭示通向突破性疗法的多组学途径。
J Transl Med. 2025 Jul 22;23(1):808. doi: 10.1186/s12967-025-06839-y.
2
Construction of a prognostic model for lung adenocarcinoma based on disulfidptosis-related lncRNAs.基于二硫键介导的铁死亡相关长链非编码RNA构建肺腺癌预后模型。
Transl Cancer Res. 2025 Jun 30;14(6):3420-3437. doi: 10.21037/tcr-2024-2256. Epub 2025 Jun 27.
3
Inflammatory Pathways and Immune Microenvironment in Non-Small Cell Lung Cancer: Multi-Dimensional Analysis and Machine Learning Prediction.

本文引用的文献

1
High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer.高分辨率单细胞图谱揭示了非小细胞肺癌中组织驻留中性粒细胞的多样性和可塑性。
Cancer Cell. 2022 Dec 12;40(12):1503-1520.e8. doi: 10.1016/j.ccell.2022.10.008. Epub 2022 Nov 10.
2
Signatures of copy number alterations in human cancer.人类癌症中拷贝数改变的特征。
Nature. 2022 Jun;606(7916):984-991. doi: 10.1038/s41586-022-04738-6. Epub 2022 Jun 15.
3
LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma.
非小细胞肺癌中的炎症途径与免疫微环境:多维分析与机器学习预测
J Cell Mol Med. 2025 Jul;29(14):e70689. doi: 10.1111/jcmm.70689.
4
Tumour and microenvironment crosstalk in NSCLC progression and response to therapy.非小细胞肺癌进展及对治疗反应中的肿瘤与微环境相互作用
Nat Rev Clin Oncol. 2025 May 16. doi: 10.1038/s41571-025-01021-1.
5
Lessons from national biobank projects utilizing whole-genome sequencing for population-scale genomics.利用全基因组测序开展人群规模基因组学研究的国家生物样本库项目经验教训。
Genomics Inform. 2025 Mar 6;23(1):8. doi: 10.1186/s44342-025-00040-9.
LRRFIP1 是一个受表观遗传调控的基因,作为一种预后生物标志物,可预测神经胶质瘤的恶性表型。
CNS Neurosci Ther. 2022 Jun;28(6):873-883. doi: 10.1111/cns.13817. Epub 2022 Mar 26.
4
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms.非小细胞肺癌的蛋白质基因组学揭示了与特定治疗靶点和免疫逃逸机制相关的分子亚型。
Nat Cancer. 2021 Nov;2(11):1224-1242. doi: 10.1038/s43018-021-00259-9. Epub 2021 Nov 22.
5
Computational approaches leveraging integrated connections of multi-omic data toward clinical applications.利用多组学数据的整合连接实现临床应用的计算方法。
Mol Omics. 2022 Jan 17;18(1):7-18. doi: 10.1039/d1mo00158b.
6
A proteogenomic portrait of lung squamous cell carcinoma.肺鳞状细胞癌的蛋白质基因组图谱。
Cell. 2021 Aug 5;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016.
7
Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes.癌症研究中的整合多组学方法:从生物网络到临床亚型
Mol Cells. 2021 Jul 31;44(7):433-443. doi: 10.14348/molcells.2021.0042.
8
A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery.一项针对 RNA-seq、融合检测和异构体定量方法的社区挑战,以用于癌症发现。
Cell Syst. 2021 Aug 18;12(8):827-838.e5. doi: 10.1016/j.cels.2021.05.021. Epub 2021 Jun 18.
9
Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.拷贝数签名分析工具及其在前列腺癌中的应用揭示了不同的突变过程和临床结局。
PLoS Genet. 2021 May 4;17(5):e1009557. doi: 10.1371/journal.pgen.1009557. eCollection 2021 May.
10
Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens.在癌症蛋白质组学数据集中,非编码基因的肽表达增加表明存在潜在的肿瘤新抗原。
Commun Biol. 2021 Apr 22;4(1):496. doi: 10.1038/s42003-021-02007-2.